Endobiliary ablation can extend survival for patients with conditions like cholangiocarcinoma and pancreatic cancers.
Category: Cancer (Page 2)
A tool created by UVA Health researchers is identifying new treatments for heart failure in drugs approved by the FDA for blood cancer.
Michael E. Williams, MD, is a hematology/oncology researcher at UVA Health, exploring ways to reduce chemotherapy use in blood cancer.
UVA Health launches 2 key clinical trials to see if immunotherapy combined with FUS tumor ablation can prevent breast cancer metastasis.
These procedures offer minimally invasive options for many conditions, including early gastrointestinal cancers.
With a first-of-its-kind focused ultrasound center & trials, UVA Health is positioned to overcome immunotherapy’s cancer-metastases limitation.
Targeting fusion proteins may provide an improved therapeutic approach for leukemia patients.
A groundbreaking clinical trial at UVA Health may shift the approach to treating glioblastoma.
Todd Bauer, MD, leads a laboratory searching for what drives chemo-resistance and metastases in his pancreatic and colorectal cancer patients.
With acute myeloid leukemia classification overseen by 3 separate guidelines, Firas El Chaer, MD, is working to bring order to the chaos.